VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,208,000 | -62.0% | 41,324 | -72.6% | 0.12% | -60.3% |
| Q4 2014 | $21,617,000 | -5.7% | 151,056 | -13.6% | 0.32% | -8.2% |
| Q3 2014 | $22,932,000 | +6.3% | 174,793 | +2.2% | 0.34% | +11.7% |
| Q2 2014 | $21,569,000 | -66.3% | 171,028 | -64.8% | 0.31% | -68.2% |
| Q1 2014 | $64,053,000 | -24.8% | 485,881 | -33.0% | 0.96% | -27.3% |
| Q4 2013 | $85,135,000 | +12.1% | 725,173 | -0.3% | 1.33% | +3.7% |
| Q3 2013 | $75,917,000 | +20.7% | 727,666 | -0.4% | 1.28% | +7.5% |
| Q2 2013 | $62,914,000 | – | 730,878 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |